RESUMEN
Aim To compare serum concentrations of tryptophane (Trp) and its metabolites in subjects with no cardiovascular disease (CVD) and patients with СVD, including arterial hypertension (AH) and ischemic heart disease (IHD).Material and methods This study included 131 participants; 58 participants (11 of them with documented peripheral atherosclerosis) were included into the AH group, 46 participants were included into the IHD group, and 27 participants with no signs of CVD were included into the control group. Plasma concentrations of Trp and its metabolites were measured by high-performance liquid chromatography in combination with a triple quadrupole analyzer.Results Comparison of the three study groups revealed significant differences in concentrations of Trp (Ñ=0.029), kynurenine (p<0.001), kynurenine/Trp ratio (p<0.001), quinolinic acid (Ñ=0.007), kynurenic acid (Ñ=0.003), serotonin (p<0.001), and 5hydroxyindoleacetic acid (5HIAA) (Ñ=0.011). When the AH group was subdivided into subgroups without and with documented peripheral atherosclerosis, the intergroup differences remained for concentrations of kynurenine, kynurenine/Trp ratio, quinolinic acid, kynurenic acid, serotonin, and 5HIAA. Also, correlations were found between concentrations of Trp metabolites and laboratory and instrumental data, primarily inflammatory markers. Conclusion Analysis of serum concentrations of Trp and its metabolites in CVD patients showed increases in kynurenine, kynurenine/Trp ratio, quinolinic acid, kynurenic acid, and 5HIAA along with decreases in concentrations of Trp and serotonin in the groups of AH, AH with documented peripheral atherosclerosis, and IHD.
Asunto(s)
Aterosclerosis , Enfermedad de la Arteria Coronaria , Hipertensión , Humanos , Quinurenina/metabolismo , Triptófano/metabolismo , Ácido Quinurénico/metabolismo , Serotonina/metabolismo , Ácido Hidroxiindolacético , Enfermedad de la Arteria Coronaria/complicaciones , Enfermedad de la Arteria Coronaria/diagnóstico , Ácido Quinolínico , Hipertensión/complicaciones , Hipertensión/diagnóstico , Aterosclerosis/complicaciones , Aterosclerosis/diagnósticoRESUMEN
THE AIM OF THE STUDY: Was to develop a method for the qualitative and quantitative determination of benzodiazepine receptor agonists (zaleplon and clobazam), taking into account different chemical structures, by high-performance liquid chromatography-high-resolution tandem mass spectrometry using Orbitrap technology for the purposes and tasks of forensic medical examination. A method has been developed for the identification and quantitative determination of zaleplon and clobazam by high-performance liquid chromatography-high-resolution tandem mass spectrometry using Orbitrap technology. The proposed identification method can be used in the future to form a database of domestic mass spectra for potent and narcotic substances.
Asunto(s)
Espectrometría de Masas en Tándem , Tecnología , Acetamidas , Cromatografía Líquida de Alta Presión , Clobazam , Pirimidinas , Espectrometría de Masas en Tándem/métodosRESUMEN
Cardiovascular disease (CVD) represents one of the main causes of mortality worldwide and nearly a half of it is related to ischemic heart disease (IHD). The article represents a comprehensive study on the diagnostics of IHD through the targeted metabolomic profiling and machine learning techniques. A total of 112 subjects were enrolled in the study, consisting of 76 IHD patients and 36 non-CVD subjects. Metabolomic profiling was conducted, involving the quantitative analysis of 87 endogenous metabolites in plasma. A novel regression method of age-adjustment correction of metabolomics data was developed. We identified 36 significantly changed metabolites which included increased cystathionine and dimethylglycine and the decreased ADMA and arginine. Tryptophan catabolism pathways showed significant alterations with increased levels of serotonin, intermediates of the kynurenine pathway and decreased intermediates of indole pathway. Amino acid profiles indicated elevated branched-chain amino acids and increased amino acid ratios. Short-chain acylcarnitines were reduced, while long-chain acylcarnitines were elevated. Based on these metabolites data, machine learning algorithms: logistic regression, support vector machine, decision trees, random forest, and gradient boosting, were used for IHD diagnostic models. Random forest demonstrated the highest accuracy with an AUC of 0.98. The metabolites Norepinephrine; Xanthurenic acid; Anthranilic acid; Serotonin; C6-DC; C14-OH; C16; C16-OH; GSG; Phenylalanine and Methionine were found to be significant and may serve as a novel preliminary panel for IHD diagnostics. Further studies are needed to confirm these findings.
Asunto(s)
Enfermedades Cardiovasculares , Isquemia Miocárdica , Humanos , Serotonina , Aminoácidos , Metabolómica/métodos , Aminoácidos de Cadena Ramificada/metabolismo , Isquemia Miocárdica/complicaciones , Enfermedades Cardiovasculares/etiologíaRESUMEN
Mouse cytochrome P450 subfamily 1A, 3A, 1E, 2C, 2D isoenzyme activities and corresponding contents were measured by means of triple quadrupole mass spectrometer in Multiple Reaction Monitoring mode (MRM). The technique was developed and tested on microsomes from control mouse and after induction with phenobarbital or methylcholanthrene. MRM allowed us to measure the content of individual P450 isoforms without using isotopic-labeled peptides or derivatization reagent. The results of modifying the content of certain P450 isoforms correlated with the change of enzymatic activity, defined by marker substrates.
Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Microsomas Hepáticos/metabolismo , Isoformas de Proteínas/metabolismo , Animales , Sistema Enzimático del Citocromo P-450/análisis , Sistema Enzimático del Citocromo P-450/química , Activación Enzimática/efectos de los fármacos , Espectrometría de Masas/métodos , Metilcolantreno/farmacología , Ratones , Microsomas Hepáticos/química , Microsomas Hepáticos/efectos de los fármacos , Fenobarbital/farmacología , Isoformas de Proteínas/análisis , Isoformas de Proteínas/química , Especificidad por SustratoRESUMEN
We found that changes in the concentrations of tryptophan metabolites in the blood serum and in the intestinal contents are one of the mechanisms for the formation of metabolic coupling in the system "macroorganism-intestinal microbiota", which undergoes significant changes in the development of obesity. Although blood kynurenine remained basically unchanged in obese children we found an increase in some of its serum metabolites: anthranilic, kynurenic and xanthurenic acids. It is noteworthy that in the analysis of fecal matter in obese children, revealed a 2-fold increase in the level of kynurenine while the concentration of kynurenine pathway metabolites corresponded to the level of the group of healthy children. This may indicate the metabolic activation of the microbiota associated with the intestinal mucosa. This is also supported by the absence of statistically significant differences in the concentration of indole in healthy children and in obese children in fecal analyses, and a significant increase in the concentration of indole-3-lactate and indole-3-acetate in the blood serum of obese children.
Asunto(s)
Obesidad Infantil , Niño , Humanos , Quinurenina , Extractos Vegetales , TriptófanoRESUMEN
Concentrations of 46 proteins have been determined in human blood plasma using PlasmaDeepDive™ MRM Panel ("Biognosys AG", Switzerland). 18 of them were included into the group of proteins with higher concentrations, also identified by the shotgun proteomic analysis. Based on literature data it is concluded that the PlasmaDeepDive™ MRM Panel is applicable for studies of human plasma samples for potential biomarkers of various nervous system disorders.
Asunto(s)
Proteínas Sanguíneas/análisis , Espectrometría de Masas/métodos , Proteómica/métodos , Humanos , Espectrometría de Masas/instrumentación , Espectrometría de Masas en Tándem/métodosRESUMEN
Molecular interactions between proteins redox partners (cytochromes Ð 450 3Ð4, 3Ð5 and cytochrome b5) within the monooxygenase system, which is known to be involved in drug biotransformation, were investigated. Human cytochromes Ð 450 3Ð4 and 3Ð5 (CYP3A4 and CYP3A5) form complexes with various cytochromes b5: the microsomal (b5mc) and mitochondrial (b5om) forms of this protein, as well as with 2 "chimeric" proteins, b5(om-mc), b5(mc-om). Kinetic constants and equilibrium dissociation constants were determined by the SPR biosensor. Essential distinction between CYP3A4 and CYP3A5 was only observed upon their interactions with cytochrome b5om. Electroanalytical characteristics of electrodes with immobilized hemoproteins were obtained. The electrochemical analysis of CYP3A4, CYP3A5, b5mc, b5om, b5(om-mc), and b5(mc-om) immobilized on screen printed graphite electrodes modified with membranous matrix revealed that these proteins have very close reduction potentials -0.435 ï¸ -0.350 V (vs. Ag/AgCl). Cytochrome b5mc was shown to be capable of stimulating the electrocatalytic activity of CYP3A4 in the presence of its substrate testosterone.
Asunto(s)
Citocromo P-450 CYP3A/química , Citocromos b5/química , Biocatálisis , Técnicas Electroquímicas , Enzimas Inmovilizadas/química , Humanos , Isoenzimas/química , Microsomas/química , Microsomas/metabolismo , Mitocondrias/química , Mitocondrias/metabolismo , Oxidación-Reducción , Análisis por Matrices de Proteínas , Unión Proteica , Proteínas Recombinantes/química , Resonancia por Plasmón de SuperficieRESUMEN
Isatin-binding activity of mice liver proteins has been investigated in the samples from the control and flight groups by using the methods of biosensor and proteomic analysis. It was found the higher isatin-binding activity in mice of flight group. The content of a number of individual isatin-binding proteins in the samples of the flight groups differ slightly from the ground control. However, in samples from animals which have weekly post-flight adaptation, the level of certain proteins was significantly increased. The latter allows us to assume that the main events in the proteome of mice (at least in subproteome of isatin-binding proteins), occurs in early post-flight period.
Asunto(s)
Adaptación Fisiológica , Proteínas Portadoras/metabolismo , Isatina/química , Vuelo Espacial , Actinas/aislamiento & purificación , Actinas/metabolismo , Alcohol Deshidrogenasa/aislamiento & purificación , Alcohol Deshidrogenasa/metabolismo , Aldehído Deshidrogenasa/aislamiento & purificación , Aldehído Deshidrogenasa/metabolismo , Animales , Proteínas Portadoras/aislamiento & purificación , Gliceraldehído-3-Fosfato Deshidrogenasas/aislamiento & purificación , Gliceraldehído-3-Fosfato Deshidrogenasas/metabolismo , Hígado/química , Ratones , Ratones Endogámicos C57BL , Peroxirredoxinas/aislamiento & purificación , Peroxirredoxinas/metabolismo , Unión Proteica , Proteoma/aislamiento & purificación , Proteoma/metabolismo , Factores de Tiempo , IngravidezRESUMEN
A method of quantitative determination of azithromycin in HPLC with mass spectrometric detection was developed. The detection limit is 0.5 ng/ml. The method was used in the study of pharmacokinetics and bioequivalence of Zi-Factor (capsules of 250 mg of azithromycin made by Veropharm, Russia) vs. reference-drug. The pharmacokinetic study was performed by the open cross randomized procedure in 18 volunteers. The pharmacokinetic parameters required for estimation of the drug bioequivalence were calculated. The statistical analysis of the pharmacokinetic parameters revealed bioequivalence of Zi-Factor and the reference-drug.
Asunto(s)
Antibacterianos/farmacocinética , Azitromicina/farmacocinética , Administración Oral , Antibacterianos/administración & dosificación , Antibacterianos/sangre , Azitromicina/administración & dosificación , Azitromicina/sangre , Cromatografía Líquida de Alta Presión/métodos , Humanos , Espectrometría de Masas , Equivalencia TerapéuticaRESUMEN
Molecular interactions between proteins redox partners (cytochromes P450 3A4, 3A5 and cytochrome b5) within the monooxygenase system, which is known to be involved in drug biotransformation, were investigated. Human cytochromes P450 3A4 and 3A5 (CYP3A4 and CYP3A5) form complexes with various cytochromes b5: the microsomal (b5mc) and mitochondrial (b5om) forms of this protein, as well as with 2 "chimeric" proteins, b5(om-mc), b5(mc-om). Kinetic constants and equilibrium dissociation constants were determined by the SPR biosensor. Essential distinction between CYP3A4 and CYP3A5 was only observed upon their interactions with cytochrome b5om. Electroanalytical characteristics of electrodes with immobilized hemoproteins were obtained. The electrochemical analysis of CYP3A4, CYP3A5, b5mc, b5om, b5(om-mc), and b5(mc-om) immobilized on screen printed graphite electrodes modified with membranous matrix revealed that these proteins have very close reduction potentials -0.435 - -0.350 V (vs. Ag/AgCl). Cytochrome b5mc was shown to be capable of stimulating the electrocatalytic activity of CYP3A4 to testosterone.
Asunto(s)
Citocromo P-450 CYP3A/química , Citocromos b5/química , Microsomas/química , Proteínas Mitocondriales/química , Proteínas Recombinantes de Fusión/química , Biocatálisis , Técnicas Biosensibles , Citocromo P-450 CYP3A/genética , Citocromos b5/genética , Técnicas Electroquímicas , Electrodos , Humanos , Proteínas Inmovilizadas/química , Proteínas Inmovilizadas/genética , Cinética , Proteínas Mitocondriales/genética , Oxidación-Reducción , Unión Proteica , Proteínas Recombinantes de Fusión/genética , Soluciones , Testosterona/químicaRESUMEN
Current review describes recent approaches of cytochrome P450 concentration and activity evaluation. Special attention paid to modem methods of proteomic analysis such as electrophoresis and chromato-mass-spectrometry. Methods of targeted proteomic applicable for quantitative and qualitative study of P450s in biological samples as well as methods for the enzyme activity measurements are reviewed. Finally, data on correlation between certain P450 isoform content and its specific enzymatic activities were described and discussed in the review.
Asunto(s)
Bioquímica/métodos , Sistema Enzimático del Citocromo P-450/análisis , Sistema Enzimático del Citocromo P-450/metabolismo , Animales , Sistema Enzimático del Citocromo P-450/química , Humanos , Mediciones Luminiscentes , Espectrometría de Masas/métodos , Proteómica/métodos , Análisis Espectral/métodosRESUMEN
Glycyrrhizic acid (GL)--one of the active components of the Russian drug formulation "Phosphogliv" possesses extremely low bioavailability. A sensitive method for GL determination in blood using high performance liquid chromatography coupled with mass-spectrometry (HPLC-MS) has been developed in order to investigate absorption characteristics of glycyrrhizic acid after peroral administration of "Phosphogliv" and GL sodium salt. Separation of blood components was achieved on the analytical reverse-phase column C18 "EcoNova" ProntoSIL, using a gradient mode. Detection of GL and an internal standard (IS) (glycyrrhetic acid) was performed using electrospray ionization with the selected ion monitoring in negative mode (SIM) using target ions at m/z 821.3 for GL and 469.3 for IS. The calibration curve was linear over the range of 50-5000 ng/ml (the correlation coefficient was 0.995). The detection limit for GL in blood was 25 ng/ml and the lower limit of quantification was 50 ng/ml. The developed method has been applied to compare absorption efficiency of glycyrrhizic acid as the component of "Phosphogliv" composition and solution of GL sodium salt during first two hours after their single peroral administration to rats at the dose of 8.5 mg/kg. It was shown that GL absorption occurs several minutes after peroral administration. Moreover, GL bioavailability after administration of drug "Phosphogliv" was higher than after administration of GL sodium salt. This difference may be attributed to incorporation of glycyrrhizic acid in the phospholipid nanoparticles structure.